Browsing by Subject "PAP, Rituximab, Alveolar macrophages, Surfactant, PPARγ, ABCG1, LPLA2"
Now showing items 1-1 of 1
-
Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis
(2012-06-14)Pulmonary Alveolar Proteinosis (PAP) patients exhibit an acquired deficiency of biologically active granulocyte-macrophage colony stimulating factor (GM-CSF) attributable to GM-CSF specific autoantibodies. PAP alveolar ...